155 related articles for article (PubMed ID: 24688146)
1. Effects of lorglumide on growth and invasion of human pancreatic cancer cell line Mia PaCa-2 in vitro through the cholecystokinin-cholecystokinin-1 receptor pathway.
Zhou J; Zhang ZX; Li DC
Curr Ther Res Clin Exp; 2010 Aug; 71(4):239-51. PubMed ID: 24688146
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Anticancer Effects of Gemcitabine with Pitavastatin on Pancreatic Cancer Cell Line MIA PaCa-2 in vitro and in vivo.
Chen YH; Chen YC; Lin CC; Hsieh YP; Hsu CS; Hsieh MC
Cancer Manag Res; 2020; 12():4645-4665. PubMed ID: 32606957
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of cholecystokinin-induced calcium mobilization in gastric antral interstitial cells of Cajal.
Gong YY; Si XM; Lin L; Lu J
World J Gastroenterol; 2012 Dec; 18(48):7184-93. PubMed ID: 23326123
[TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin B-type receptor signaling is involved in human pancreatic cancer cell growth.
Kaufmann R; Schafberg H; Rudroff C; Henklein P; Nowak G
Neuropeptides; 1997 Dec; 31(6):573-83. PubMed ID: 9574824
[TBL] [Abstract][Full Text] [Related]
5. Enhanced survival in perineural invasion of pancreatic cancer: an in vitro approach.
Dai H; Li R; Wheeler T; Ozen M; Ittmann M; Anderson M; Wang Y; Rowley D; Younes M; Ayala GE
Hum Pathol; 2007 Feb; 38(2):299-307. PubMed ID: 17097719
[TBL] [Abstract][Full Text] [Related]
6. [MiR-150-5p inhibits the proliferation and promoted apoptosis of pancreatic cancer cells].
Sun Y; Jin XL; Zhang TT; Jia CW; Chen J
Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):460-4. PubMed ID: 24246865
[TBL] [Abstract][Full Text] [Related]
7. [Effect of Hematopoietic Pre-B-cell Leukemia Transcription Factor Interacting Protein Knockdown on Proliferation,Cell Cycle and Apoptosis in Pancreatic Cancer Cells].
Zhao YM; Yang G; You L; Hu Y; Zhao YP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Feb; 42(1):7-15. PubMed ID: 32131934
[No Abstract] [Full Text] [Related]
8. Cholecystokinin analog, JMV-180, stimulates growth of human pancreatic cancer.
Swift IR; Smith JP
Dig Dis Sci; 1994 May; 39(5):1007-13. PubMed ID: 8174413
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of angiopoietin-2 suppresses metastasis in human pancreatic carcinoma by reduced matrix metalloproteinase-2.
Zhang ZX; Zhou J; Zhang Y; Zhu DM; Li DC; Zhao H
Mol Biotechnol; 2013 Mar; 53(3):336-44. PubMed ID: 22457202
[TBL] [Abstract][Full Text] [Related]
10. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
Bi YL; Min M; Shen W; Liu Y
Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of either cholecystokinin receptor subtype reduces while antagonists potentiate or sensitize a morphine-induced excitatory response.
Felicio LF; Mazzini BK; Cacheiro RG; Cruz TN; Flório JC; Nasello AG
Peptides; 2001 Aug; 22(8):1299-304. PubMed ID: 11457524
[TBL] [Abstract][Full Text] [Related]
12. Heptadecanoic Acid, an Odd-Chain Fatty Acid, Induces Apoptosis and Enhances Gemcitabine Chemosensitivity in Pancreatic Cancer Cells.
Kim HY; Moon JY; Cho SK
J Med Food; 2023 Mar; 26(3):201-210. PubMed ID: 36716276
[TBL] [Abstract][Full Text] [Related]
13. Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat.
Scarpignato C; Varga G; Dobronyi I; Papp M
Br J Pharmacol; 1989 Mar; 96(3):661-9. PubMed ID: 2470456
[TBL] [Abstract][Full Text] [Related]
14. Cholecystokinin receptors in human pancreatic cancer cell lines.
Mandair KK; Towner P; Stamford IF; Morris JD; Harper E; Benjamin IS; Tavares IA
Eur J Cancer; 1998 Aug; 34(9):1455-9. PubMed ID: 9849431
[TBL] [Abstract][Full Text] [Related]
15. Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells.
Tang XP; Tang GD; Fang CY; Liang ZH; Zhang LY
World J Gastroenterol; 2013 Mar; 19(10):1582-92. PubMed ID: 23538603
[TBL] [Abstract][Full Text] [Related]
16. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
[TBL] [Abstract][Full Text] [Related]
17. Selective CCK-A but not CCK-B receptor antagonists inhibit HT-29 cell proliferation: synergism with pharmacological levels of melatonin.
González-Puga C; García-Navarro A; Escames G; León J; López-Cantarero M; Ros E; Acuña-Castroviejo D
J Pineal Res; 2005 Oct; 39(3):243-50. PubMed ID: 16150104
[TBL] [Abstract][Full Text] [Related]
18. [In vitro interaction of human pancreatic cancer cells and rat dorsal root ganglia: a co-culture model].
Liu ZS; Wang Y; Li Q; Zhang SL; Shi YR
Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):259-63. PubMed ID: 22781036
[TBL] [Abstract][Full Text] [Related]
19. Grape-seed procyanidins inhibit the in vitro growth and invasion of pancreatic carcinoma cells.
Chung YC; Huang CC; Chen CH; Chiang HC; Chen KB; Chen YJ; Liu CL; Chuang LT; Liu M; Hsu CP
Pancreas; 2012 Apr; 41(3):447-54. PubMed ID: 22015975
[TBL] [Abstract][Full Text] [Related]
20. Effect of deramciclane, a new 5-HT receptor antagonist, on cholecystokinin-induced changes in rat gastrointestinal function.
Varga G; Kordás K; Burghardt B; Gacsályi I; Szénási G
Eur J Pharmacol; 1999 Feb; 367(2-3):315-23. PubMed ID: 10079007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
